We wanted to update you on our recent activities.

Here are the latest posts last week:

‍Blogs :

Dr. Kamdar on the Benefits of Liso-Cel Therapy Across Lymphoma Subgroups

FDA Approval Insights: Denileukin Diftitox for R/R Cutaneous T-Cell Lymphoma

MCH Minute Unavailable

Initiating CML Treatment: Collaborative Approaches for Improved Outcomes

‍Also at MCH the News and Tweets never stop flowing!

Join Us at www.mycancerhaven.org

‍The Team @ MCHFollow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok

Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.